Literature DB >> 18651102

Efficacy of early dental and ENT therapy in preventing nephropathy in pediatric Henoch-Schönlein purpura.

Chiyoko N Inoue1, Takako Nagasaka, Sachiko Matsutani, Masako Ishidoya, Rikako Homma, Yasushi Chiba.   

Abstract

In a previous study, we demonstrated the benefit of tonsillectomy for early recovery from Henoch-Schönlein purpura (HSP) nephritis (HSPN), suggesting the pathological role of tonsils in HSP (Inoue et al., Clin Nephrol 67:298-305, 2007). In this study, we evaluated the efficacy of extensive eradication of infectious foci directly connected to the tonsils, including those involved in oral as well as ear, nose, and throat (ENT) diseases, in reducing the nephropathy in HSP. For this purpose, we examined the focal points of infection in 40 newly diagnosed HSP patients. After these focal points of infection had been identified, they were extensively eradicated; when the clinical course was intractable, we also considered tonsillectomy. After administering such therapy to HSP patients, we prospectively followed them up for 0.6 to 8 years. The identified focal infections included dental caries in 28 (70%), apical periodontitis in 21 (53%), rhinosinusitis in 19 (48%), tonsillitis in five (13%), and otitis media in four (10%) of the 40 patients. Seventeen patients (43%) had more than two simultaneous infectious foci, whereas, in five (13%), no infectious focus was found. In 32 patients, antimicrobial treatment with concurrent dental and/or ENT therapy resulted in a complete cure without development of HSPN or recurrent attacks. In eight patients, we performed tonsillectomy-adenotonsillectomy to treat their clinical symptoms, including aggravated purpura and recurrent attacks of HSP or HSPN. All patients were completely cured. The overall incidence of HSPN was only three out of the 40 patients (8%). Oral and ENT diseases were found with high percentages in HSP patients. Early and extensive treatment for these lesions and tonsillectomy-adenotonsillectomy for intractable cases may prevent the complication of HSPN, contributing to the early curing of HSP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651102     DOI: 10.1007/s10067-008-0954-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Present status of concept of focal infection.

Authors:  G H COLEMAN
Journal:  J Am Med Assoc       Date:  1953-01-24

Review 2.  Apical periodontitis: a dynamic encounter between root canal infection and host response.

Authors:  P N Nair
Journal:  Periodontol 2000       Date:  1997-02       Impact factor: 7.589

3.  Prevalence of sinusitis signs in a non-ENT population.

Authors:  F Gordts; P A Clement; T Buisseret
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1996 Nov-Dec       Impact factor: 1.538

4.  Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan.

Authors:  Kenji Suzuki; Tadao Nishimura; Shunkichi Baba
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

5.  Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Y Ogura; S Suzuki; T Shirakawa; M Masuda; H Nakamura; K Iijima; N Yoshikawa
Journal:  Am J Kidney Dis       Date:  2000-07       Impact factor: 8.860

6.  Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura.

Authors:  N D Rosenblum; H S Winter
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

Review 7.  Pediatric sinusitis.

Authors:  Michael Zacharisen; Ryan Casper
Journal:  Immunol Allergy Clin North Am       Date:  2005-05       Impact factor: 3.479

8.  HLA-DR antigen expression in tonsillar epithelium. With special reference to focal infection.

Authors:  T Kimura; K Fujiwara; K Kuki; Y Hayashi; T Tabata
Journal:  Acta Otolaryngol       Date:  1990 Nov-Dec       Impact factor: 1.494

9.  Influence of tonsillar disease on the expression of J chain by immunoglobulin-producing cells in human palatine and nasopharyngeal tonsils.

Authors:  F R Korsrud; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

10.  Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis.

Authors:  N Yoshikawa; R H White; A H Cameron
Journal:  Clin Nephrol       Date:  1981-11       Impact factor: 0.975

View more
  4 in total

1.  High prevalence of sinusitis in children with henoch-schönlein purpura.

Authors:  Haruna Nakaseko; Osamu Uemura; Takuhito Nagai; Satoshi Yamakawa; Yoshiko Hibi; Yasuhito Yamasaki; Masaki Yamamoto
Journal:  Int J Pediatr       Date:  2011-10-02

2.  Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric henoch-schönlein purpura nephritis in children.

Authors:  Hiroaki Kanai; Emi Sawanobori; Anna Kobayashi; Kyoko Matsushita; Kanji Sugita; Kosuke Higashida
Journal:  Nephron Extra       Date:  2011-10-14

3.  Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient.

Authors:  Hiroaki Kanai; Anna Kobayashi; Kyoko Matsushita; Emi Sawanobori; Kanji Sugita; Kosuke Higashida
Journal:  CEN Case Rep       Date:  2013-01-12

4.  Rhinosinusitis in children.

Authors:  Sukhbir K Shahid
Journal:  ISRN Otolaryngol       Date:  2012-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.